Regeneron (REGN) affirms FY16 Eylea guidance - Bloomberg
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Regeneron (NASDAQ: REGN) affirms FY16 Eylea guidance, according to Bloomberg, citing conference commentary today. The company stated that it was "just being realistic."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regeneron (REGN): Dermatology Survey Confirms Bullish Outlook - Leerink
- Kirby Corp. (KEX) Tops Q3 EPS by 4c, Offers Q4 Guidance
- Realty Income (O) Reports In-Line Q3 FFO
Create E-mail Alert Related CategoriesGuidance, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!